Acadia Pharmaceuticals elects Biggar to board
This article was originally published in Scrip
Executive Summary
Acadia Pharmaceuticals, a company developing treatments for neurological and related central nervous system disorders, has appointed Stephen Biggar to its board of directors. Dr Biggar currently serves as a partner at life sciences investment company Baker Brothers Investments.